Renewable energy

Technavvio says OTC drugs have become a preferred option for the treatment of allergic rhinitis globally

  This market research report includes a detailed segmentation of the global allergic rhinitis drugs market based on the class of drugs (antihistamines, intranasal corticosteroids, and immunotherapies), and by route of administration (oral, parenteral, and intranasal). It also outlines the market shares of key regions such as the Americas, APAC, and Europe. The key vendors…

Read More
Renewable energy

Technavio expects global gastroesophageal reflux disease (GERD) market to reach over $8 billion by 2020

  This industry research report includes a detailed segmentation of the global GERD market by drug class (proton pumps inhibitors, H2 receptor antagonists, antacids, prokinetics, and CAM), by route of administration (oral and parenteral), and by dosage form (solid and liquids). It also outlines the market shares for key regions such as the Americas, APAC,…

Read More
Renewable energy

Pharmerging market expected to surpass $600 billion in terms of revenue by 2020, says Technavio

  Technavio has released updated information on the pharmaceutical market, with the publication of its new market research report, pharmerging markets. The pharmerging markets is expected to grow at a CAGR of around 13% between 2016 and 2020. China, Brazil, Russia, and India are the major revenue contributors, accounting for over 50% of total market…

Read More
Renewable energy

Global protein therapeutics market expected to reach over $210 billion by 2020, says Technavio

  Protein therapeutics: Key market research findings Increase use of targeted therapies High demand for monoclonal antibodies Technavio has added a new market research report on the global protein therapeutics market, which is expected to grow at a CAGR of around 8% between 2016 and 2020. Factors that can be attributed to the growth of…

Read More
Renewable energy

Global hormone replacement therapy market expected to surpass $6 million by 2019, says Technavio

  Hormone replacement therapy: Key market research findings Technological advancements in drug delivery systems Rise in estrogen replacement therapies Technavio has added a new market research report on the global hormone replacement therapy market, to its therapeutics portfolio. Technavio’s market analysts estimate the global hormone replacement therapy market to grow at a CAGR of more…

Read More
Renewable energy

Shifting Focus to Untapped Markets Spurring Growth Opportunities in the Global Biologic Therapeutics Market: Technavio Report

  The key vendors in the global biologic therapeutics market 2015-2019 are Amgen, F. Hoffmann-La Roche, Novo Nordisk, and Sanofi. London, 19 October 2015: Technavio, an independent tech-focused global research firm, has announced the publication of its market research report on the global biologic therapeutics market 2015-2019. Emergence of targeted and combination therapies is one…

Read More
Renewable energy

China’s drug eluting stent market expected to reach over US $772 million by 2019, says Technavio

  Drug eluting stents: Key market research findings Technological advancements and redesigning drug-eluting stents Increased usage of hybrid processes in CVDs Technavio has added a new market research report on the drug eluting stent market in China, to its stent market. The drug eluting stent market in China is expected to grow at a CAGR…

Read More
Renewable energy

Global liver diseases therapeutics market expected to reach US $45 million by 2019, says Technavio

  This market research report from Technavio segments the global liver diseases therapeutics market by disease indication (hepatitis, liver cirrhosis, and liver cancer), by type of molecule (biologics and small molecules), and by geography (Americas, EMEA, and APAC). Leading vendors analyzed in this market study are F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson,…

Read More